Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cytomegalovirus Infections × Valganciclovir × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Other hematologic neoplasm 1 Myeloid 1 Lymphoid 1 Dermatologic 1 Classical hematology 1 CNS 1

Conditions

Glioblastoma 2 Cytomegalovirus Infections 1 Brain Neoplasms 1

Interventions

Valganciclovir 1 Polymerase Chain Reaction 1 Flow Cytometry 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00400322 2021-03-01

Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection

Karolinska Institutet

Phase NA Completed

Cytomegalovirus Infections, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡